Related Experiment Video
Updated: Jun 16, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Temporal order memory differences in Alzheimer's disease and vascular dementia
Benjamin M Hampstead1, David J Libon, Stephen T Moelter
1VA RR&D Center of Excellence, Atlanta VA Medical Center, Decatur, GA 30033, USA. bhampst@emory.edu
Journal of Clinical and Experimental Neuropsychology
|January 21, 2010
Summary
Vascular dementia patients struggle more with event sequencing than Alzheimer's disease patients, indicating frontal-subcortical roles in temporal order memory.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Accurate memory recollection relies on determining the order of events.
- This ability is associated with both frontal and medial temporal lobe functions.
- Vascular dementia (VaD) and Alzheimer's disease (AD) are characterized by distinct patterns of frontal-subcortical and medial temporal dysfunction, respectively.
Purpose of the Study:
- To assess and compare the temporal ordering abilities of patients with VaD and AD.
- To investigate how memory load affects ordering performance in these patient groups.
- To elucidate the specific brain regions involved in temporal order memory.
Main Methods:
- A novel sequencing task was developed to progressively increase memory load.
- Patients with VaD and AD performed this task.
- Performance metrics included error rates and selection of previously encountered stimuli.
Main Results:
- VaD patients made significantly more errors than AD patients.
- VaD patients selected previously encountered stimuli more often than AD patients.
- Curve analysis indicated a general decline in ordering for VaD, while AD errors were more load-dependent.
Conclusions:
- Findings support the crucial role of frontal-subcortical networks in temporal order memory.
- The results differentiate the memory deficits in VaD and AD based on ordering abilities.
- This study provides insights into the neural underpinnings of event sequencing in dementia.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...